SCHEMBL17877968

SCHEMBL17877968

c1ccc(-n2c3ccccc3c3c(-c4ccc(-c5cccc6c5c5ccccc5n6-c5ccccc5)c5ccccc45)cccc32)cc1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.61
L3MBTL1 Q9Y468 3/20 0.61
ATM Q13315 1/20 0.61
MAPK1 P28482 1/20 0.38
ALDH1A1 P00352 4/20 0.38
KMT2A Q03164 3/20 0.38
MAPK8 P45983 2/20 0.38
MAPT P10636 2/20 0.38
HTT P42858 2/20 0.38
KEAP1 Q14145 2/20 0.38
NFE2L2 Q16236 2/20 0.38
USP2 O75604 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
IL1R1 P14778 1/20 0.38
PGR P06401 1/20 0.38
MAPK9 P45984 1/20 0.37
MEN1 O00255 1/20 0.37
CRHBP P24387 1/20 0.37
CRHR2 Q13324 1/20 0.37
POLB P06746 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11998218 0.96 L3MBTL1 (0.65) KDM4EL3MBTL1ATMMAPK1ALDH1A1
SCHEMBL17953780 0.95 KDM4E (0.55) KDM4EL3MBTL1ATMMAPK1ALDH1A1
SCHEMBL17953761 0.95 KDM4E (0.55) KDM4EL3MBTL1ATMMAPK1ALDH1A1
SCHEMBL17953687 0.95 KDM4E (0.55) KDM4EL3MBTL1ATMMAPK1ALDH1A1
SCHEMBL18561901 0.94 L3MBTL1 (0.63) KDM4EL3MBTL1ATMMAPK1ALDH1A1
SCHEMBL23989180 0.91 KDM4E (0.50) KDM4EL3MBTL1ATMMAPK1ALDH1A1
SCHEMBL17777669 0.91 KDM4E (0.50) KDM4EL3MBTL1ATMALDH1A1KMT2A
SCHEMBL15435976 0.89 L3MBTL1 (0.62) KDM4EL3MBTL1ATMMAPK1ALDH1A1
SCHEMBL17229071 0.89 L3MBTL1 (0.57) KDM4EL3MBTL1ATMMAPK1ALDH1A1
SCHEMBL11998227 0.89 L3MBTL1 (0.59) KDM4EL3MBTL1ATMMAPK1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9985217-B2 Material for organic electroluminescent device and organic electroluminescent device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2018-05-29 US disclosed
US-9985217-B2 Material for organic electroluminescent device and organic electroluminescent device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2018-05-29 US disclosed
US-20160190468-A1 MATERIAL FOR ORGANIC ELECTROLUMINESCENT DEVICE AND ORGANIC ELECTROLUMINESCENT DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2016-06-30 US disclosed
US-20160190468-A1 MATERIAL FOR ORGANIC ELECTROLUMINESCENT DEVICE AND ORGANIC ELECTROLUMINESCENT DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2016-06-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160190468-A1 MATERIAL FOR ORGANIC ELECTROLUMINESCENT DEVICE AND ORGANIC ELECTROLUMINESCENT DEVICE INCLUDING THE SAME L1CAM, ODC1, OR10J3 KDM4E 746/4885L3MBTL1 483/4885ATM 1298/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.